UNSPSC 51262406: Reproterol

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51262406

Definition

This classification denotes a metaproterenol analog, adrenergic beta-agonists, and bronchodilator agent with the molecular formula C18H23N5O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 11941YC6RN, chemically known as 1,2,3,6-tetrahydro-1,3-dimethyl-7-(3-((beta,3,5-trihydroxyphenethyl)amino)propyl)-2,6-purindion but generally known as reproterol, which bears US NIH Compound Identifier 25654. European Medicines Agency schedules Reproterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10283MIG.

Read the full definition

World Health Organization schedules reproterol in its Anatomical Therapeutic Chemical (ATC) Classification. REPROTEROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule reproterol under HS 29395900 and SITC 54145. As of Q4 2014, REPROTEROL remains the US FDA Preferred Term for this commodity. SMILES: OC(CNCCCN1C2C(N(C(=O)N(C2=O)C)C)NC1)C1CC(O)CC(O)C1.

About UNSPSC 51262406

UNSPSC 51262406 Reproterol is a Commodity code that designates pharmaceutical products, though the recent state and local activity tagged under it does not align with reproterol procurement. Instead, the single recent solicitation under this code involves naloxone and drug deactivation systems—harm-reduction and public-health products used by county health departments to address opioid overdose and controlled-substance management. State and local governments buying under this code are primarily county-level health and community health agencies managing overdose-response and substance-abuse initiatives. The scope of work centers on annual purchases of finished naloxone units and Safe Drug Deactivation Systems in moderate quantities, with quarterly delivery schedules to centralized community health facilities and associated shipping and logistics coordination.

Seminole County, Florida posted the most recent opportunity under this code—IFB 60459723LAS, released June 30, 2026, for 1,900 units of naloxone and 800 Safe Drug Deactivation Systems annually with a response deadline of July 26, 2023 (note: a discrepancy between posted date and deadline in the source). The procurement is structured as a competitive invitation for bid with an initial two-year term and one-year renewal option, quarterly deliveries to the Seminole County Community Health Building in Sanford, and all shipping costs included in vendor pricing. Bidders must meet E-Verify and drug-free workplace compliance, maintain commercial general liability and workers' compensation insurance, and accept a three-month probationary termination clause. The code shows minimal recent activity; this single Seminole County solicitation represents the available state and local opportunity record for reproterol category procurement.

Quick answers

What is UNSPSC 51262406?

UNSPSC 51262406 is Reproterol, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51262406?

UNSPSC 51262406 maps to 1 NIGP code, 26912 Autonomic Drugs.

On GovTribe

See everything under UNSPSC 51262406

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code